🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
April 2026
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(840)
All (840)
Buys (57)
Sells (783)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
COGNITION THERAPEUTICS INC
(CGTX)
Caggiano Anthony
— Chief Medical Officer
Apr 16, 2026
Purchase
Shares
10,000
Price
$1.11
Total Value
$11.10K
Shares Held After
874,906
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Milestone Pharmaceuticals Inc.
(MIST)
Oliveto Joseph
— Director
Apr 16, 2026
Sale
Shares
36,500
Price
$2.26
Total Value
$82.49K
Shares Held After
446,244
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
12
Price
$164.12
Total Value
$1.97K
Shares Held After
14,666
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
36
Price
$163.21
Total Value
$5.88K
Shares Held After
14,678
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
76
Price
$162.26
Total Value
$12.33K
Shares Held After
14,714
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
240
Price
$161.61
Total Value
$38.79K
Shares Held After
14,790
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
201
Price
$160.35
Total Value
$32.23K
Shares Held After
15,030
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
219
Price
$159.81
Total Value
$35.00K
Shares Held After
15,231
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
216
Price
$158.28
Total Value
$34.19K
Shares Held After
15,450
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Pharvaris N.V.
(PHVS)
Modig Berndt
— Director
Apr 16, 2026
Sale
Shares
2,292
Price
$28.60
Total Value
$65.56K
Shares Held After
139,792
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Apr 16, 2026
Sale
Shares
7,748
Price
$6.40
Total Value
$49.59K
Shares Held After
387,769
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Apogee Therapeutics, Inc.
(APGE)
Henderson Jane
— Chief Financial Officer
Apr 16, 2026
Sale
Shares
2,000
Price
$90.00
Total Value
$180.00K
Shares Held After
175,371
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Birchler Brian
— EVP, Corp and Development Ops
Apr 16, 2026
Sale
Shares
973
Price
$75.04
Total Value
$73.02K
Shares Held After
67,500
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Jenne Kyle
— EVP, Chf GL Pdt Str Ofcr
Apr 16, 2026
Sale
Shares
4,902
Price
$75.17
Total Value
$368.49K
Shares Held After
23,713
% of Holdings
17.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Baroldi Joseph
— EVP, Chief Business Officer
Apr 16, 2026
Sale
Shares
5,619
Price
$74.56
Total Value
$418.95K
Shares Held After
46,535
% of Holdings
10.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alector, Inc.
(ALEC)
Wong-Sarad Grace
— Principal Accounting Officer
Apr 16, 2026
Sale
Shares
1,820
Price
$2.65
Total Value
$4.82K
Shares Held After
104,645
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Lillie James Woodruff
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
2,097
Price
$27.49
Total Value
$57.65K
Shares Held After
295,157
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Lillie James Woodruff
— Chief Scientific Officer
Apr 16, 2026
Sale
Shares
686
Price
$27.01
Total Value
$18.53K
Shares Held After
297,254
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Setia Vishwas
— Chief Financial Officer
Apr 16, 2026
Sale
Shares
87
Price
$27.49
Total Value
$2.39K
Shares Held After
392,627
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Setia Vishwas
— Chief Financial Officer
Apr 16, 2026
Sale
Shares
29
Price
$27.01
Total Value
$783.29
Shares Held After
392,714
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Hanson Kristopher
— General Counsel
Apr 16, 2026
Sale
Shares
225
Price
$27.49
Total Value
$6.19K
Shares Held After
190,165
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Hanson Kristopher
— General Counsel
Apr 16, 2026
Sale
Shares
73
Price
$27.01
Total Value
$1.97K
Shares Held After
190,390
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Kersten Dirk
— Director
Apr 16, 2026
Sale
Shares
6,657
Price
$20.06
Total Value
$133.52K
Shares Held After
4,544,773
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Kersten Dirk
— Director
Apr 16, 2026
Sale
Shares
11,116
Price
$21.10
Total Value
$234.59K
Shares Held After
4,551,430
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
Apr 16, 2026
Sale
Shares
7,575
Price
$27.49
Total Value
$208.24K
Shares Held After
1,630,564
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Kroeger Christopher A.
— Director
Apr 16, 2026
Sale
Shares
2,477
Price
$27.01
Total Value
$66.90K
Shares Held After
1,638,139
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Foff Erin Pennock
— Chief Medical Officer
Apr 16, 2026
Sale
Shares
881
Price
$27.49
Total Value
$24.22K
Shares Held After
400,777
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Foff Erin Pennock
— Chief Medical Officer
Apr 16, 2026
Sale
Shares
288
Price
$27.01
Total Value
$7.78K
Shares Held After
401,658
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Apr 16, 2026
Sale
Shares
825
Price
$145.79
Total Value
$120.28K
Shares Held After
301,185
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Apr 16, 2026
Sale
Shares
2,255
Price
$144.66
Total Value
$326.21K
Shares Held After
302,010
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Apr 16, 2026
Sale
Shares
5,373
Price
$143.81
Total Value
$772.69K
Shares Held After
304,265
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Apr 16, 2026
Sale
Shares
2,246
Price
$142.99
Total Value
$321.16K
Shares Held After
309,638
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
160
Price
$581.33
Total Value
$93.01K
Shares Held After
40,513
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
385
Price
$579.84
Total Value
$223.24K
Shares Held After
40,673
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
1,750
Price
$579.36
Total Value
$1.01M
Shares Held After
41,058
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
2,027
Price
$578.05
Total Value
$1.17M
Shares Held After
42,808
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
2,048
Price
$577.03
Total Value
$1.18M
Shares Held After
44,835
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
930
Price
$575.99
Total Value
$535.67K
Shares Held After
46,883
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
1,800
Price
$574.79
Total Value
$1.03M
Shares Held After
47,813
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Apr 16, 2026
Sale
Shares
400
Price
$573.96
Total Value
$229.58K
Shares Held After
49,613
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Whitehawk Therapeutics, Inc.
(WHWK)
Giacobello Scott M.
— CHIEF FINANCIAL OFFICER
Apr 16, 2026
Sale
Shares
141,600
Price
$4.13
Total Value
$584.81K
Shares Held After
295,224
% of Holdings
32.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
40
Price
$581.64
Total Value
$23.27K
Shares Held After
18,876
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
160
Price
$581.08
Total Value
$92.97K
Shares Held After
18,916
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,454
Price
$579.64
Total Value
$842.79K
Shares Held After
19,076
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,066
Price
$578.83
Total Value
$617.03K
Shares Held After
20,530
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
2,085
Price
$577.87
Total Value
$1.20M
Shares Held After
21,596
% of Holdings
8.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
2,206
Price
$576.91
Total Value
$1.27M
Shares Held After
23,681
% of Holdings
8.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
789
Price
$575.64
Total Value
$454.18K
Shares Held After
25,887
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,680
Price
$574.73
Total Value
$965.55K
Shares Held After
26,676
% of Holdings
5.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Apr 16, 2026
Sale
Shares
520
Price
$573.91
Total Value
$298.44K
Shares Held After
28,356
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 151–200 of 840 transactions (page 4 of 17)
Version: v26.3.33